National reach MHC operates a national footprint with dispensing facilities across multiple states and is capable of servicing patients in all 50 states, presenting a broad market for pharmacy services, infusion solutions, and specialty care partnerships.

Specialty focus Strong emphasis on chronic and complex conditions (HIV, autoimmune disorders, transplant, cystic fibrosis, hepatitis C) and infusion therapies, suggesting opportunities for expanding specialty pharmacy collaborations, patient management programs, and payer negotiations.

Centers leverage Five COE aligned units (TLCRx, Modern Health Specialty Pharmacy, Biofusion, Infusion Services, Infusion Therapy of Texas) indicate integrated care and potential for cross-sell bundled infusion, clinical services, and coordinated care pathways.

Leadership & growth Experienced leadership with a history of acquisitions and specialty pharmacy leadership points to potential for strategic partnerships, MSP collaborations, and scale-focused sales conversations with decision-makers.

Financial opportunites Current revenue in the lower mid-range and a sizable patient base (serving over 15,000 patients monthly) imply opportunities for cost-saving programs, expanded payer contracting, and value-based care initiatives tied to chronic disease management.